A phase II study of additional effect of palliative radiotherapy combined with immune check point inhibitors plus chemotherapy for patients with advanced non-small-cell lung cancer.

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2020
This article has no abstract
Epistemonikos ID: 009381f605bd2839931532e7d1c87d88cdc0f2d0
First added on: Apr 11, 2025